Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1185

1.

Consensus Recommendations for the Clinical Management of Patients With Multiple Myeloma Treated With Selinexor.

Mikhael J, Noonan KR, Faiman B, Gleason C, Nooka AK, Costa LJ, Jagannath S, Richardson PG, Siegel D, Chari A, Lentzch S.

Clin Lymphoma Myeloma Leuk. 2020 Mar 7. pii: S2152-2650(20)30011-2. doi: 10.1016/j.clml.2019.12.026. [Epub ahead of print] No abstract available.

PMID:
32245742
2.

The oceans' twilight zone must be studied now, before it is too late.

Martin A, Boyd P, Buesseler K, Cetinic I, Claustre H, Giering S, Henson S, Irigoien X, Kriest I, Memery L, Robinson C, Saba G, Sanders R, Siegel D, Villa-Alfageme M, Guidi L.

Nature. 2020 Apr;580(7801):26-28. doi: 10.1038/d41586-020-00915-7. No abstract available.

PMID:
32235941
3.

Machine Learning and the Future of Medicare Fraud Detection.

Gordon D, Siegel D.

J Am Acad Dermatol. 2020 Mar 28. pii: S0190-9622(20)30481-3. doi: 10.1016/j.jaad.2020.03.059. [Epub ahead of print] No abstract available.

PMID:
32234308
4.

Targeting MCL-1 in hematologic malignancies: Rationale and progress.

Wei AH, Roberts AW, Spencer A, Rosenberg AS, Siegel D, Walter RB, Caenepeel S, Hughes P, McIver Z, Mezzi K, Morrow PK, Stein A.

Blood Rev. 2020 Feb 21:100672. doi: 10.1016/j.blre.2020.100672. [Epub ahead of print] Review.

PMID:
32204955
5.

Low-temperature paddlewheel effect in glassy solid electrolytes.

Smith JG, Siegel DJ.

Nat Commun. 2020 Mar 20;11(1):1483. doi: 10.1038/s41467-020-15245-5.

6.

Treatment of Smoldering Myeloma: Problems With Study Design as well as Biological and Clinical Implications.

Biran N, Vesole DH, Donato ML, Ip A, Kaur G, Goldberg S, Siegel DS.

J Clin Oncol. 2020 Mar 11:JCO1902972. doi: 10.1200/JCO.19.02972. [Epub ahead of print] No abstract available.

PMID:
32160077
7.

The evolving maintenance of certification process: update on the financial status of the medical boards.

Schwartz Z, Lieberman MR, Siegel DM.

Dermatol Online J. 2020 Jan 15;26(1). pii: 13030/qt93p2d3n2.

8.

Once- versus twice-weekly carfilzomib in relapsed and refractory multiple myeloma by select patient characteristics: phase 3 A.R.R.O.W. study subgroup analysis.

Dimopoulos MA, Niesvizky R, Weisel K, Siegel DS, Hajek R, Mateos MV, Cavo M, Huang M, Zahlten-Kumeli A, Moreau P.

Blood Cancer J. 2020 Mar 9;10(3):35. doi: 10.1038/s41408-020-0300-y.

9.

Commentary on Light Emitting Diode-Based Photodynamic Therapy for Photoaging, Scars, and Dyspigmentation.

Geisler A, Siegel DM.

Dermatol Surg. 2020 Mar 4. doi: 10.1097/DSS.0000000000002350. [Epub ahead of print] No abstract available.

PMID:
32141927
10.

How Can Phytoplankton Pigments Be Best Used to Characterize Surface Ocean Phytoplankton Groups for Ocean Color Remote Sensing Algorithms?

Kramer SJ, Siegel DA.

J Geophys Res Oceans. 2019 Nov;124(11):7557-7574. doi: 10.1029/2019JC015604. Epub 2019 Nov 11.

11.

Total Synthesis of Micrococcin P1 through Scalable Thiazole Forming Reactions of Cysteine Derivatives and Nitriles.

Christy MP, Johnson T, McNerlin CD, Woodard J, Nelson AT, Lim B, Hamilton TL, Freiberg KM, Siegel D.

Org Lett. 2020 Mar 20;22(6):2365-2370. doi: 10.1021/acs.orglett.0c00202. Epub 2020 Mar 5.

PMID:
32134277
12.

Clinical and histologic presentation of pediatric reactive granulomatous dermatitis.

Akinshemoyin Vaughn OL, Siegel DH, Chiu YE, DeBord LC, Hogeling M, Hunt RD, Nguyen C, Sokumbi O, Verbsky JW, Arkin LM.

Pediatr Dermatol. 2020 Mar 1. doi: 10.1111/pde.14137. [Epub ahead of print]

PMID:
32115758
13.

Once-weekly (70 mg/m2 ) vs twice-weekly (56 mg/m2 ) dosing of carfilzomib in patients with relapsed or refractory multiple myeloma: A post hoc analysis of the ENDEAVOR, A.R.R.O.W., and CHAMPION-1 trials.

Moreau P, Stewart KA, Dimopoulos M, Siegel D, Facon T, Berenson J, Raje N, Berdeja JG, Orlowski RZ, Yang H, Ma H, Klippel Z, Zahlten-Kumeli A, Mezzi K, Iskander K, Mateos MV.

Cancer Med. 2020 Feb 28. doi: 10.1002/cam4.2945. [Epub ahead of print]

14.

Global chemical effects of the microbiome include new bile-acid conjugations.

Quinn RA, Melnik AV, Vrbanac A, Fu T, Patras KA, Christy MP, Bodai Z, Belda-Ferre P, Tripathi A, Chung LK, Downes M, Welch RD, Quinn M, Humphrey G, Panitchpakdi M, Weldon KC, Aksenov A, da Silva R, Avila-Pacheco J, Clish C, Bae S, Mallick H, Franzosa EA, Lloyd-Price J, Bussell R, Thron T, Nelson AT, Wang M, Leszczynski E, Vargas F, Gauglitz JM, Meehan MJ, Gentry E, Arthur TD, Komor AC, Poulsen O, Boland BS, Chang JT, Sandborn WJ, Lim M, Garg N, Lumeng JC, Xavier RJ, Kazmierczak BI, Jain R, Egan M, Rhee KE, Ferguson D, Raffatellu M, Vlamakis H, Haddad GG, Siegel D, Huttenhower C, Mazmanian SK, Evans RM, Nizet V, Knight R, Dorrestein PC.

Nature. 2020 Mar;579(7797):123-129. doi: 10.1038/s41586-020-2047-9. Epub 2020 Feb 26.

PMID:
32103176
15.

Impact of Personal Protective Equipment on the Performance of Emergency Pediatric Tasks.

Adler MD, Krug S, Eiger C, Good GL, Kou M, Nash M, Henretig FM, Hornik CP, Gosnell L, Chen JY, Debski J, Sharma G, Siegel D, Donoghue AJ; Best Pharmaceuticals for Children Act–Pediatric Trials Network¶¶.

Pediatr Emerg Care. 2020 Feb 24. doi: 10.1097/PEC.0000000000002028. [Epub ahead of print]

PMID:
32097378
16.

Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials.

Gavriatopoulou M, Chari A, Chen C, Bahlis N, Vogl DT, Jakubowiak A, Dingli D, Cornell RF, Hofmeister CC, Siegel D, Berdeja JG, Reece D, White D, Lentzsch S, Gasparetto C, Huff CA, Jagannath S, Baz R, Nooka AK, Richter J, Abonour R, Parker TL, Yee AJ, Moreau P, Lonial S, Tuchman S, Weisel KC, Mohty M, Choquet S, Unger TJ, Li K, Chai Y, Li L, Shah J, Shacham S, Kauffman MG, Dimopoulos MA.

Leukemia. 2020 Feb 24. doi: 10.1038/s41375-020-0756-6. [Epub ahead of print]

PMID:
32094461
17.

CRISPR-engineered T cells in patients with refractory cancer.

Stadtmauer EA, Fraietta JA, Davis MM, Cohen AD, Weber KL, Lancaster E, Mangan PA, Kulikovskaya I, Gupta M, Chen F, Tian L, Gonzalez VE, Xu J, Jung IY, Melenhorst JJ, Plesa G, Shea J, Matlawski T, Cervini A, Gaymon AL, Desjardins S, Lamontagne A, Salas-Mckee J, Fesnak A, Siegel DL, Levine BL, Jadlowsky JK, Young RM, Chew A, Hwang WT, Hexner EO, Carreno BM, Nobles CL, Bushman FD, Parker KR, Qi Y, Satpathy AT, Chang HY, Zhao Y, Lacey SF, June CH.

Science. 2020 Feb 28;367(6481). pii: eaba7365. doi: 10.1126/science.aba7365. Epub 2020 Feb 6.

PMID:
32029687
18.

Access to Mohs micrographic surgery through the Veterans Choice Program of the United States Department of Veterans Affairs.

Siegel D, Joo JS, Cortez RA, Furlong TA, Isseroff RR.

J Am Acad Dermatol. 2020 Jan 29. pii: S0190-9622(20)30135-3. doi: 10.1016/j.jaad.2020.01.051. [Epub ahead of print] No abstract available.

PMID:
32006603
19.

Bispecific and split CAR T cells targeting CD13 and TIM3 eradicate acute myeloid leukemia.

He X, Feng Z, Ma J, Ling S, Cao Y, Gurung B, Wu Y, Katona BW, O'Dwyer KP, Siegel DL, June CH, Hua X.

Blood. 2020 Mar 5;135(10):713-723. doi: 10.1182/blood.2019002779.

PMID:
31951650
20.

Rubella Vaccine Persistence Within Cutaneous Granulomas in Common Variable Immunodeficiency Disorder.

Bender NR, Cardwell LA, Siegel D, Sokumbi O.

Am J Dermatopathol. 2020 Jan 2. doi: 10.1097/DAD.0000000000001598. [Epub ahead of print]

PMID:
31899704
21.

Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome.

Zhang A, Duchatelet S, Lakdawala N, Tower RL, Diamond C, Marathe K, Hill I, Richard G, Diab Y, Kirkorian AY, Watanabe F, Siegel DH, Hovnanian A.

JAMA Dermatol. 2020 Jan 2. doi: 10.1001/jamadermatol.2019.4141. [Epub ahead of print]

PMID:
31895414
22.

CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration.

Nobles CL, Sherrill-Mix S, Everett JK, Reddy S, Fraietta JA, Porter DL, Frey N, Gill SI, Grupp SA, Maude SL, Siegel DL, Levine BL, June CH, Lacey SF, Melenhorst JJ, Bushman FD.

J Clin Invest. 2020 Feb 3;130(2):673-685. doi: 10.1172/JCI130144.

23.

Superior Vena Cava Duplication: The Red Herring of Central Line Placement.

Gunther K, Lam C, Siegel D.

Case Rep Surg. 2019 Nov 20;2019:6401236. doi: 10.1155/2019/6401236. eCollection 2019.

24.

Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome.

Olsen GM, Hansen LM, Stefanko NS, Mathes E, Puttgen KB, Tollefson MM, Lauren C, Mancini AJ, McCuaig CC, Frieden IJ, Adams D, Baselga E, Chamlin S, Gupta D, Frommelt P, Garzon MC, Horii K, Klajn J, Maheshwari M, Newell B, Nguyen HL, Nopper A, Powell J, Siegel DH, Drolet BA.

JAMA Dermatol. 2019 Dec 11. doi: 10.1001/jamadermatol.2019.3839. [Epub ahead of print]

PMID:
31825455
25.

Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge.

Choi H, Kudchodkar SB, Reuschel EL, Asija K, Borole P, Agarwal S, Van Gorder L, Reed CC, Gulendran G, Ramos S, Broderick KE, Kim JJ, Ugen KE, Kobinger G, Siegel DL, Weiner DB, Muthumani K.

Hum Vaccin Immunother. 2019 Dec 4:1-12. doi: 10.1080/21645515.2019.1688038. [Epub ahead of print]

PMID:
31799896
26.

Global satellite-observed daily vertical migrations of ocean animals.

Behrenfeld MJ, Gaube P, Della Penna A, O'Malley RT, Burt WJ, Hu Y, Bontempi PS, Steinberg DK, Boss ES, Siegel DA, Hostetler CA, Tortell PD, Doney SC.

Nature. 2019 Dec;576(7786):257-261. doi: 10.1038/s41586-019-1796-9. Epub 2019 Nov 27.

PMID:
31776517
27.

Update: Interim Guidance for Health Care Providers for Managing Patients with Suspected E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, November 2019.

Jatlaoui TC, Wiltz JL, Kabbani S, Siegel DA, Koppaka R, Montandon M, Adkins SH, Weissman DN, Koumans EH, O'Hegarty M, O'Sullivan MC, Ritchey MD, Chatham-Stephens K, Kiernan EA, Layer M, Reagan-Steiner S, Legha JK, Shealy K, King BA, Jones CM, Baldwin GT, Rose DA, Delaney LJ, Briss P, Evans ME; Lung Injury Response Clinical Working Group.

MMWR Morb Mortal Wkly Rep. 2019 Nov 22;68(46):1081-1086. doi: 10.15585/mmwr.mm6846e2.

28.

SNARE proteins rescue impaired autophagic flux in Down syndrome.

Aivazidis S, Jain A, Rauniyar AK, Anderson CC, Marentette JO, Orlicky DJ, Fritz KS, Harris PS, Siegel D, Maclean KN, Roede JR.

PLoS One. 2019 Nov 12;14(11):e0223254. doi: 10.1371/journal.pone.0223254. eCollection 2019.

29.

Update: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury - United States, October 2019.

Siegel DA, Jatlaoui TC, Koumans EH, Kiernan EA, Layer M, Cates JE, Kimball A, Weissman DN, Petersen EE, Reagan-Steiner S, Godfred-Cato S, Moulia D, Moritz E, Lehnert JD, Mitchko J, London J, Zaki SR, King BA, Jones CM, Patel A, Delman DM, Koppaka R; Lung Injury Response Clinical Working Group; Lung Injury Response Epidemiology/Surveillance Group.

MMWR Morb Mortal Wkly Rep. 2019 Oct 18;68(41):919-927. doi: 10.15585/mmwr.mm6841e3.

30.

Hamartomas and midline anomalies in association with infantile hemangiomas, PHACE, and LUMBAR syndromes.

Stefanko NS, Davies OMT, Beato MJ, Blei F, Drolet BA, Fairley J, Frieden IJ, Galligan ER, Goddard D, Howard R, Husain S, Lauren CT, Lopez-Gutierrez JC, MacArthur C, Metry DW, Morel KD, Niedt GW, Garzon MC, Sokumbi O, Siegel DH.

Pediatr Dermatol. 2020 Jan;37(1):78-85. doi: 10.1111/pde.14006. Epub 2019 Oct 20.

PMID:
31631401
31.

Pomalidomide plus low-dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure.

Siegel DS, Schiller GJ, Song KW, Agajanian R, Stockerl-Goldstein K, Kaya H, Sebag M, Samaras C, Malek E, Talamo G, Seet CS, Mouro J, Pierceall WE, Zafar F, Chung W, Srinivasan S, Agarwal A, Bahlis NJ.

Br J Haematol. 2020 Feb;188(4):501-510. doi: 10.1111/bjh.16213. Epub 2019 Oct 6.

32.

Predicting Wettability and the Electrochemical Window of Lithium-Metal/Solid Electrolyte Interfaces.

Kim K, Siegel DJ.

ACS Appl Mater Interfaces. 2019 Oct 30;11(43):39940-39950. doi: 10.1021/acsami.9b13311. Epub 2019 Oct 17.

PMID:
31576739
33.

T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma.

Garfall AL, Dancy EK, Cohen AD, Hwang WT, Fraietta JA, Davis MM, Levine BL, Siegel DL, Stadtmauer EA, Vogl DT, Waxman A, Rapoport AP, Milone MC, June CH, Melenhorst JJ.

Blood Adv. 2019 Oct 8;3(19):2812-2815. doi: 10.1182/bloodadvances.2019000600. No abstract available.

34.

CAR T cell viability release testing and clinical outcomes: is there a lower limit?

Chong EA, Levine BL, Grupp SA, Davis MM, Siegel DL, Maude SL, Gladney WL, Frey NV, Porter DL, Hwang WT, Chong ER, June CH, Schuster SJ.

Blood. 2019 Nov 21;134(21):1873-1875. doi: 10.1182/blood.2019002258. No abstract available.

PMID:
31554634
35.

Gut bacteria responding to dietary change encode sialidases that exhibit preference for red meat-associated carbohydrates.

Zaramela LS, Martino C, Alisson-Silva F, Rees SD, Diaz SL, Chuzel L, Ganatra MB, Taron CH, Secrest P, Zuñiga C, Huang J, Siegel D, Chang G, Varki A, Zengler K.

Nat Microbiol. 2019 Dec;4(12):2082-2089. doi: 10.1038/s41564-019-0564-9. Epub 2019 Sep 23.

36.

Stereochemistry of Linoleic Acid Esters of Hydroxy Linoleic Acids.

Wang H, Kolar MJ, Chang T, Rizo J, Konduri S, McNerlin C, Saghatelian A, Siegel D.

Org Lett. 2019 Oct 4;21(19):8080-8084. doi: 10.1021/acs.orglett.9b03054. Epub 2019 Sep 23.

PMID:
31545060
37.

Postoperative ultrasound evaluation for deep vein thrombosis after knee replacement surgery performed with tranexamic acid.

Gerstein NS, Cushnyr BW, Petersen TR, Siegel D.

Minerva Anestesiol. 2020 Feb;86(2):217-218. doi: 10.23736/S0375-9393.19.13916-8. Epub 2019 Sep 13. No abstract available.

38.

Thermodynamic Assessment of Coating Materials for Solid-State Li, Na, and K Batteries.

Yu S, Park H, Siegel DJ.

ACS Appl Mater Interfaces. 2019 Oct 9;11(40):36607-36615. doi: 10.1021/acsami.9b11001. Epub 2019 Sep 30.

PMID:
31522493
39.

Seascape genetics of the stalked kelp Pterygophora californica and comparative population genetics in the Santa Barbara Channel.

Hargarten HL, Johansson ML, Reed DC, Coelho NC, Siegel DA, Alberto F.

J Phycol. 2020 Feb;56(1):110-120. doi: 10.1111/jpy.12918. Epub 2019 Nov 6.

PMID:
31513719
40.

Accuracy of a smartphone application for triage of skin lesions based on machine learning algorithms.

Udrea A, Mitra GD, Costea D, Noels EC, Wakkee M, Siegel DM, de Carvalho TM, Nijsten TEC.

J Eur Acad Dermatol Venereol. 2020 Mar;34(3):648-655. doi: 10.1111/jdv.15935. Epub 2019 Oct 8.

PMID:
31494983
41.

EFFECT OF LUBRICANTS ON CORNEAL THICKNESS AFTER VITRECTOMY.

Siegel DT, Hubbard GB, Yan J, Cribbs B, Jain N, Yeh S, Bui D, Smith J, Barb S, Pearce W, Ward L, Hendrick AM.

Retina. 2019 Aug 30. doi: 10.1097/IAE.0000000000002639. [Epub ahead of print]

PMID:
31490296
42.

PAHSAs enhance hepatic and systemic insulin sensitivity through direct and indirect mechanisms.

Zhou P, Santoro A, Peroni OD, Nelson AT, Saghatelian A, Siegel D, Kahn BB.

J Clin Invest. 2019 Oct 1;129(10):4138-4150. doi: 10.1172/JCI127092.

43.

PAHSAs attenuate immune responses and promote β cell survival in autoimmune diabetic mice.

Syed I, Rubin de Celis MF, Mohan JF, Moraes-Vieira PM, Vijayakumar A, Nelson AT, Siegel D, Saghatelian A, Mathis D, Kahn BB.

J Clin Invest. 2019 Aug 5;129:3717-3731. doi: 10.1172/JCI122445. eCollection 2019 Aug 5.

44.

Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma.

Gluck WL, Gounder MM, Frank R, Eskens F, Blay JY, Cassier PA, Soria JC, Chawla S, de Weger V, Wagner AJ, Siegel D, De Vos F, Rasmussen E, Henary HA.

Invest New Drugs. 2019 Jul 29. doi: 10.1007/s10637-019-00840-1. [Epub ahead of print]

PMID:
31359240
45.

Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma.

Landgren O, Sonneveld P, Jakubowiak A, Mohty M, Iskander KS, Mezzi K, Siegel DS.

Leukemia. 2019 Sep;33(9):2127-2143. doi: 10.1038/s41375-019-0517-6. Epub 2019 Jul 24. Review.

46.

Corrigendum: Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month followup of negative test results and utility data from a large US registry study.

Ferris LK, Rigel DS, Siegel DM, Skelsey MK, Peck GL, Hren C, Gorman C, Frumento T, Jansen B, Yao Z, Rock J, Knezevich SR, Cockerell CJ.

Dermatol Online J. 2019 Jun 6;25(6). pii: 13030/qt452297hk.

47.

Modification of genital kidney nephrons for sperm transport in a plethodontid salamander, Eurycea longicauda.

Hartley J, Gribbins KM, Siegel DS.

J Morphol. 2019 Oct;280(10):1452-1461. doi: 10.1002/jmor.21041. Epub 2019 Jul 17.

PMID:
31313860
48.

A dose-ranging, parallel group, split-face, single-blind phase II study of light emitting diode-red light (LED-RL) for skin scarring prevention: study protocol for a randomized controlled trial.

Nguyen JK, Weedon J, Jakus J, Heilman E, Isseroff RR, Siegel DM, Jagdeo JR.

Trials. 2019 Jul 15;20(1):432. doi: 10.1186/s13063-019-3546-6.

49.

Costello syndrome: Clinical phenotype, genotype, and management guidelines.

Gripp KW, Morse LA, Axelrad M, Chatfield KC, Chidekel A, Dobyns W, Doyle D, Kerr B, Lin AE, Schwartz DD, Sibbles BJ, Siegel D, Shankar SP, Stevenson DA, Thacker MM, Weaver KN, White SM, Rauen KA.

Am J Med Genet A. 2019 Sep;179(9):1725-1744. doi: 10.1002/ajmg.a.61270. Epub 2019 Jun 20.

PMID:
31222966
50.

Natural history of PHACE syndrome: A survey of adults with PHACE.

Stefanko NS, Cossio ML, Powell J, Blei F, Davies OMT, Frieden IJ, Garzon MC, Lauren CT, Maheshwari M, McCuaig CC, Metry D, Salman S, Drolet BA, Siegel DH.

Pediatr Dermatol. 2019 Sep;36(5):618-622. doi: 10.1111/pde.13871. Epub 2019 Jun 20.

PMID:
31222913

Supplemental Content

Loading ...
Support Center